Robert Joseph Smith - 07 Nov 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
07 Nov 2024
Net transactions value
$0
Form type
4
Filing time
12 Nov 2024, 17:00:29 UTC
Previous filing
14 Aug 2024
Next filing
16 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +125,000 $0.000000 125,000 07 Nov 2024 Common Stock 125,000 $0.3800 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 75,000 07 Nov 2024 Common Stock 75,000 $0.6900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
F2 The options are vested in full and exercisable immediately.